Mermaid Medical Group® Introduces Full Core Biopsy Device
Mermaid Medical Group is excited to introduce its latest product addition: the Full Core Biopsy Device - designed with both optimal biopsy sample quality and user ergonomics in mind.
News
Microwave Ablation for Uterine Fibroids
Mermaid Medical Group® is excited to announce that our partner, Danderyd Hospital in Sweden, is now offering microwave ablation (MWA) as a treatment for uterine fibroids, following the success of several clinical studies.
Mermaid Medical Group® Now Offers CPD-Accredited LATP Workshops in the UK
As of February 2025, Mermaid Medical is offering CPD-accredited workshops focused on Local Anaesthetic Transperineal Prostate (LATP) biopsy procedures.
Mermaid Medical Group® Announces First European TP Pivot Pro™ Cases Successfully Performed by Prof. Hashim U. Ahmed
Following the recent UKCA approval of TP Pivot Pro™, Prof. Hashim U. Ahmed has successfully performed the first European cases of transperineal prostate biopsies with the disposable needle guide designed by CIVCO Medical Solutions.
Mermaid Medical Group® & Front Line Medical Technologies Inc. Announce UK Launch of COBRA-OS®
Mermaid Medical Group® Announces Exclusive Distribution Agreement for COBRA-OS® Device in the UK for REBOA Procedures with Front Line Medical Technologies Inc.
Mermaid Medical Group® Announces UKCA Approval for the Advanced TP Pivot Pro™
With its recent UKCA approval, Mermaid Medical is ready to introduce the TP Pivot Pro™ to UK healthcare professionals.
ISO 14001 Certified: Small (Action) Steps Toward a Greener Future
2024 marks a significant milestone in our journey toward sustainability - we achieved ISO 14001 certification, underscoring our commitment to reducing our environmental footprint.
Mermaid Medical Group® and Front Line Medical Technologies Inc. Announce Exclusive Distribution Agreement for REBOA Device
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Welcoming Marcus Kildegaard Nielsen as Sales Director for Mermaid Medical Group®
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.